Researchers have identified a novel molecule that effectively halts the progression of triple-negative breast cancer (TNBC), an aggressive and difficult-to-treat form of the disease. The molecule, referred to as ‘RBO-1′ in the study, works by targeting a specific cellular pathway crucial for the cancer cells’ survival and spread. In laboratory models, RBO-1 demonstrated a significant ability to stop tumor growth and prevent metastasis without causing severe toxicity to healthy cells. The discovery, published in a leading scientific journal, represents a promising new direction for developing targeted therapies against TNBC, which currently has limited treatment options. Further preclinical studies are planned to advance this potential therapy toward clinical trials. Read the full article at: https://www.sciencedaily.com/releases/2026/03/260309225146.htm